CIK 0001799448
- Non-accelerated filer
- Smaller reporting company
Aligos Therapeutics, Inc.
Sign in to watch- Ticker
- ALGS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 800-466-6059
- Business address
- ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-08 | Quan Lucinda Y. | Grant or award · Stock Option (Right to Buy) | +48,000 | 48,000 | ||
| 2023-03-15 | Quan Lucinda Y. | Grant or award · Stock Option (Right to Buy) | +78,750 | 78,750 | ||
| 2022-07-07 | Quan Lucinda Y. | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | ||
| 2022-02-04 | Quan Lucinda Y. | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2022-02-04 | Quan Lucinda Y. | Grant or award · Stock Option (Right to Buy) | +26,250 | 26,250 | ||
| 2020-12-01 | Quan Lucinda Y. | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2020-10-20 | Quan Lucinda Y. | Conversion | +6,835 | 6,835 | ||
| 2020-10-20 | Quan Lucinda Y. | Conversion | +1,697 | 8,532 | ||
| 2020-10-20 | Quan Lucinda Y. | Conversion | +726 | 9,258 | ||
| 2020-10-20 | Quan Lucinda Y. | Conversion · Series A Preferred Stock | −6,835 | 0 | ||
| 2020-10-20 | Quan Lucinda Y. | Conversion · Series B-1 Preferred Stock | −1,697 | 0 | ||
| 2020-10-20 | Quan Lucinda Y. | Conversion · Series B-2 Preferred Stock | −726 | 0 |
Page 1 of 1 · 12 trades